Towards Healthcare
Biochip Market to Surge USD 42.15 Bn by 2034

Biochip Market Expansion 2025 Driven by Genomics Demand

Projections indicate that, biochip industry is projected to rise from USD 12.75 billion in 2024 to USD 42.15 billion by 2034, reflecting a CAGR of 12.7% over the next decade. The biochip market is growing because biochips have many applications, such as medical diagnostics, drug development, personalized medicine, continuous health monitoring, neurostimulation, assistive services, and smart healthcare systems. North America is dominant in the market due to significant government funding and massive investments in biotechnology research.

Content

  • Last Updated: 01 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The biochip market in 2025 is valued at USD 14.37 billion and is projected to climb to USD 42.15 billion by 2034, with a CAGR of 12.7% over the forecast period.

North America is currently leading the biochip market share 40% due to the presence of major key players and strong R&D investment.

The biochip market includes six segments by chip type/product, by offering/product category, by application/end market, by technology/platform, by end-user, and by region.

Some key players include Illumina, Inc., Thermo Fisher Scientific, Roche Diagnostics, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions